# A Phase 1 Study of ANJ900 Chinese Healthy Subjects

> **NCT05151146** · PHASE1 · COMPLETED · sponsor: **Anji Pharma** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ANJ900
- **DRUG:** Metformin IR

## Key facts

- **NCT ID:** NCT05151146
- **Lead sponsor:** Anji Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-15
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-02-28
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2022-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05151146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05151146, "A Phase 1 Study of ANJ900 Chinese Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05151146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*